APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herpes Simplex Virus (HSV) Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Herpes Simplex Virus (HSV) Vaccines Market Analysis and Forecast 2026-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchHerpes Simplex Virus (HSV) Vaccines Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Herpes Simplex Virus (HSV) Vaccines Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Herpes Simplex Virus (HSV) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herpes Simplex Virus (HSV) Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Herpes Simplex Virus (HSV) Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Herpes Simplex Virus (HSV) Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Herpes Simplex Virus (HSV) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Herpes Simplex Virus (HSV) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Herpes Simplex Virus (HSV) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Herpes Simplex Virus (HSV) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Herpes Simplex Virus (HSV) Vaccines include Sanofi, GlaxoSmithKline, Vical and Genocea Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Herpes Simplex Virus (HSV) Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Herpes Simplex Virus (HSV) Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Herpes Simplex Virus (HSV) Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Herpes Simplex Virus (HSV) Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Herpes Simplex Virus (HSV) Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Herpes Simplex Virus (HSV) Vaccines sales, projected growth trends, production technology, application and end-user industry.

Herpes Simplex Virus (HSV) Vaccines Segment by Company

Sanofi

GlaxoSmithKline

Vical

Genocea Biosciences

Herpes Simplex Virus (HSV) Vaccines Segment by Type

VCL-HB01

HSV529

GEN-003

Others

Herpes Simplex Virus (HSV) Vaccines Segment by Application

HSV-1 (Oral Herpes)

HSV-2 (Genital Herpes)

Herpes Simplex Virus (HSV) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herpes Simplex Virus (HSV) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herpes Simplex Virus (HSV) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herpes Simplex Virus (HSV) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Herpes Simplex Virus (HSV) Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Herpes Simplex Virus (HSV) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Herpes Simplex Virus (HSV) Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. VCL-HB01 Major Manufacturers Table 3. HSV529 Major Manufacturers Table 4. GEN-003 Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. HSV-1 (Oral Herpes) Major Manufacturers Table 8. HSV-2 (Genital Herpes) Major Manufacturers Table 9. Herpes Simplex Virus (HSV) Vaccines Industry Trends Table 10. Herpes Simplex Virus (HSV) Vaccines Industry Drivers Table 11. Herpes Simplex Virus (HSV) Vaccines Industry Opportunities and Challenges Table 12. Herpes Simplex Virus (HSV) Vaccines Industry Restraints Table 13. Global Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2021-2026) Table 17. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2027-2032) Table 18. Global Herpes Simplex Virus (HSV) Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021-2026) & (k units) Table 20. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2027-2032) & (k units) Table 21. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2021-2026) Table 22. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2027-2032) Table 23. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2021-2026) Table 27. Global Herpes Simplex Virus (HSV) Vaccines Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Herpes Simplex Virus (HSV) Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Herpes Simplex Virus (HSV) Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Herpes Simplex Virus (HSV) Vaccines Manufacturers, Product Type & Application Table 31. Global Herpes Simplex Virus (HSV) Vaccines Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Herpes Simplex Virus (HSV) Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2021-2026) Table 38. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2027-2032) Table 39. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 41. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2027-2032) & (k units) Table 42. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2021-2026) Table 43. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2027-2032) Table 44. Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2021-2026) & (US$/unit) Table 45. Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2027-2032) & (US$/unit) Table 46. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2021-2026) Table 50. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2027-2032) Table 51. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 53. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2027-2032) & (k units) Table 54. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2021-2026) Table 55. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2027-2032) Table 56. Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2021-2026) & (US$/unit) Table 57. Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2027-2032) & (US$/unit) Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Sanofi Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 62. Sanofi Recent Development Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 67. GlaxoSmithKline Recent Development Table 68. Vical Company Information Table 69. Vical Business Overview Table 70. Vical Herpes Simplex Virus (HSV) Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Vical Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 72. Vical Recent Development Table 73. Genocea Biosciences Company Information Table 74. Genocea Biosciences Business Overview Table 75. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 77. Genocea Biosciences Recent Development Table 78. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 79. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 80. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 81. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2027-2032) & (k units) Table 82. North America Herpes Simplex Virus (HSV) Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 83. North America Herpes Simplex Virus (HSV) Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 84. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 87. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2027-2032) & (k units) Table 88. North America Herpes Simplex Virus (HSV) Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 89. North America Herpes Simplex Virus (HSV) Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 90. North America Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 92. North America Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 93. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 94. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 95. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2027-2032) & (k units) Table 96. North America Herpes Simplex Virus (HSV) Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 97. North America Herpes Simplex Virus (HSV) Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 98. United States Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 99. Canada Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 100. Mexico Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 101. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 104. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2027-2032) & (k units) Table 105. Europe Herpes Simplex Virus (HSV) Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 106. Europe Herpes Simplex Virus (HSV) Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 107. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 110. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2027-2032) & (k units) Table 111. Europe Herpes Simplex Virus (HSV) Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 112. Europe Herpes Simplex Virus (HSV) Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 113. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 117. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 118. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2027-2032) & (k units) Table 119. Europe Herpes Simplex Virus (HSV) Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 120. Europe Herpes Simplex Virus (HSV) Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 121. Germany Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 122. France Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 123. U.K. Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 124. Italy Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 125. Russia Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 126. Spain Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 127. Netherlands Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 128. Switzerland Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 129. Sweden Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 130. Poland Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 131. China Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 132. China Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 133. China Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 134. China Herpes Simplex Virus (HSV) Vaccines Sales by Type (2027-2032) & (k units) Table 135. China Herpes Simplex Virus (HSV) Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 136. China Herpes Simplex Virus (HSV) Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 137. China Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 138. China Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 139. China Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 140. China Herpes Simplex Virus (HSV) Vaccines Sales by Application (2027-2032) & (k units) Table 141. China Herpes Simplex Virus (HSV) Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 142. China Herpes Simplex Virus (HSV) Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 143. Asia Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 146. Asia Herpes Simplex Virus (HSV) Vaccines Sales by Type (2027-2032) & (k units) Table 147. Asia Herpes Simplex Virus (HSV) Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 148. Asia Herpes Simplex Virus (HSV) Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 149. Asia Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 152. Asia Herpes Simplex Virus (HSV) Vaccines Sales by Application (2027-2032) & (k units) Table 153. Asia Herpes Simplex Virus (HSV) Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 154. Asia Herpes Simplex Virus (HSV) Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 155. Asia Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Asia Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Asia Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 159. Asia Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 160. Asia Herpes Simplex Virus (HSV) Vaccines Sales by Country (2027-2032) & (k units) Table 161. Asia Herpes Simplex Virus (HSV) Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 162. Asia Herpes Simplex Virus (HSV) Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 163. Japan Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 164. South Korea Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 165. India Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 166. Australia Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 167. Taiwan Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 168. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 169. SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 170. SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 171. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 172. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales by Type (2027-2032) & (k units) Table 173. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 174. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 175. SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 178. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales by Application (2027-2032) & (k units) Table 179. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 180. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 181. SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 185. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 186. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales by Country (2027-2032) & (k units) Table 187. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 188. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 189. Brazil Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 190. Argentina Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 191. Chile Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 192. Colombia Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 193. Peru Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 194. Saudi Arabia Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 195. Israel Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 196. UAE Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 197. Turkey Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 198. Iran Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 199. Egypt Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Herpes Simplex Virus (HSV) Vaccines Distributors List Table 203. Herpes Simplex Virus (HSV) Vaccines Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Herpes Simplex Virus (HSV) Vaccines Image Figure 2. Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herpes Simplex Virus (HSV) Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. VCL-HB01 Image Figure 5. HSV529 Image Figure 6. GEN-003 Image Figure 7. Others Image Figure 8. Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Herpes Simplex Virus (HSV) Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 10. HSV-1 (Oral Herpes) Image Figure 11. HSV-2 (Genital Herpes) Image Figure 12. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Figure 14. Global Herpes Simplex Virus (HSV) Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2021-2032) Figure 17. Global Herpes Simplex Virus (HSV) Vaccines Sales (2021-2032) & (k units) Figure 18. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Herpes Simplex Virus (HSV) Vaccines Sales YoY (2021-2032) & (k units) Figure 21. Europe Herpes Simplex Virus (HSV) Vaccines Sales YoY (2021-2032) & (k units) Figure 22. China Herpes Simplex Virus (HSV) Vaccines Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Herpes Simplex Virus (HSV) Vaccines Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales YoY (2021-2032) & (k units) Figure 25. Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2021-2032) Figure 31. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2021-2032) Figure 34. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2021-2032) Figure 37. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2021-2032) Figure 40. North America Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2021-2032) Figure 41. North America Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2021-2032) Figure 42. North America Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2021-2032) Figure 43. North America Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2021-2032) Figure 44. North America Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country (2021-2032) Figure 45. North America Herpes Simplex Virus (HSV) Vaccines Sales Share by Country (2021-2032) Figure 46. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2021-2032) Figure 47. Europe Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2021-2032) Figure 48. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2021-2032) Figure 49. Europe Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2021-2032) Figure 50. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country (2021-2032) Figure 51. Europe Herpes Simplex Virus (HSV) Vaccines Sales Share by Country (2021-2032) Figure 52. China Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2021-2032) Figure 53. China Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2021-2032) Figure 54. China Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2021-2032) Figure 55. China Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2021-2032) Figure 56. Asia Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2021-2032) Figure 57. Asia Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2021-2032) Figure 58. Asia Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2021-2032) Figure 59. Asia Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2021-2032) Figure 60. Asia Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country (2021-2032) Figure 61. Asia Herpes Simplex Virus (HSV) Vaccines Sales Share by Country (2021-2032) Figure 62. SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2021-2032) Figure 63. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2021-2032) Figure 64. SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2021-2032) Figure 65. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2021-2032) Figure 66. SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country (2021-2032) Figure 67. SAMEA Herpes Simplex Virus (HSV) Vaccines Sales Share by Country (2021-2032) Figure 68. Herpes Simplex Virus (HSV) Vaccines Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Herpes Simplex Virus (HSV) Vaccines Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • VCL-HB01
  • HSV529
  • GEN-003
  • Others
Applications
  • HSV-1 (Oral Herpes)
  • HSV-2 (Genital Herpes)
Companies covered
  • Sanofi
  • GlaxoSmithKline
  • Vical
  • Genocea Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Herpes Simplex Virus (HSV) Vaccines Market by Type
  3. 1.2.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 VCL-HB01
  5. 1.2.3 HSV529
  6. 1.2.4 GEN-003
  7. 1.2.5 Others
  8. 1.3 Herpes Simplex Virus (HSV) Vaccines Market by Application
  9. 1.3.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 HSV-1 (Oral Herpes)
  11. 1.3.3 HSV-2 (Genital Herpes)
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Herpes Simplex Virus (HSV) Vaccines Market Dynamics
  1. 2.1 Herpes Simplex Virus (HSV) Vaccines Industry Trends
  2. 2.2 Herpes Simplex Virus (HSV) Vaccines Industry Drivers
  3. 2.3 Herpes Simplex Virus (HSV) Vaccines Industry Opportunities and Challenges
  4. 2.4 Herpes Simplex Virus (HSV) Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region
  3. 3.2.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region
  9. 3.4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers
  6. 4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Herpes Simplex Virus (HSV) Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Herpes Simplex Virus (HSV) Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Herpes Simplex Virus (HSV) Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Herpes Simplex Virus (HSV) Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Herpes Simplex Virus (HSV) Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Herpes Simplex Virus (HSV) Vaccines Tier 1, Tier 2, and Tier 3
5 Herpes Simplex Virus (HSV) Vaccines Market by Type
  1. 5.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type
  2. 5.1.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type
  6. 5.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Type
6 Herpes Simplex Virus (HSV) Vaccines Market by Application
  1. 6.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application
  2. 6.1.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application
  6. 6.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 GlaxoSmithKline
  8. 7.2.1 GlaxoSmithKline Company Information
  9. 7.2.2 GlaxoSmithKline Business Overview
  10. 7.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  12. 7.2.5 GlaxoSmithKline Recent Developments
  13. 7.3 Vical
  14. 7.3.1 Vical Company Information
  15. 7.3.2 Vical Business Overview
  16. 7.3.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Vical Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  18. 7.3.5 Vical Recent Developments
  19. 7.4 Genocea Biosciences
  20. 7.4.1 Genocea Biosciences Company Information
  21. 7.4.2 Genocea Biosciences Business Overview
  22. 7.4.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  24. 7.4.5 Genocea Biosciences Recent Developments
8 North America
  1. 8.1 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Type
  2. 8.1.1 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Herpes Simplex Virus (HSV) Vaccines Price by Type (2021-2032)
  5. 8.2 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Application
  6. 8.2.1 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Herpes Simplex Virus (HSV) Vaccines Price by Application (2021-2032)
  9. 8.3 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country
  10. 8.3.1 North America Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Herpes Simplex Virus (HSV) Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Type
  2. 9.1.1 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Herpes Simplex Virus (HSV) Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Application
  6. 9.2.1 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Herpes Simplex Virus (HSV) Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country
  10. 9.3.1 Europe Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Herpes Simplex Virus (HSV) Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Herpes Simplex Virus (HSV) Vaccines Market Size by Type
  2. 10.1.1 China Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Herpes Simplex Virus (HSV) Vaccines Price by Type (2021-2032)
  5. 10.2 China Herpes Simplex Virus (HSV) Vaccines Market Size by Application
  6. 10.2.1 China Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Herpes Simplex Virus (HSV) Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Herpes Simplex Virus (HSV) Vaccines Market Size by Type
  2. 11.1.1 Asia Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Herpes Simplex Virus (HSV) Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Herpes Simplex Virus (HSV) Vaccines Market Size by Application
  6. 11.2.1 Asia Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Herpes Simplex Virus (HSV) Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Herpes Simplex Virus (HSV) Vaccines Market Size by Country
  10. 11.3.1 Asia Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Herpes Simplex Virus (HSV) Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Herpes Simplex Virus (HSV) Vaccines Market Size by Type
  2. 12.1.1 SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Herpes Simplex Virus (HSV) Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Herpes Simplex Virus (HSV) Vaccines Market Size by Application
  6. 12.2.1 SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Herpes Simplex Virus (HSV) Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Herpes Simplex Virus (HSV) Vaccines Market Size by Country
  10. 12.3.1 SAMEA Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Herpes Simplex Virus (HSV) Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Herpes Simplex Virus (HSV) Vaccines Value Chain Analysis
  2. 13.1.1 Herpes Simplex Virus (HSV) Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Herpes Simplex Virus (HSV) Vaccines Production Mode & Process
  6. 13.2 Herpes Simplex Virus (HSV) Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Herpes Simplex Virus (HSV) Vaccines Distributors
  9. 13.2.3 Herpes Simplex Virus (HSV) Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst